← Open Payments lookup

DWIGHT WILLIAMS: Open Payments

NPI 1619930591 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$567 in 29 payments from 10 companies in 2025. Trend: 2023 $666 · 2024 $671 · 2025 $567

Food & beverage: $567
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP2$156
ABBVIE INC.12$135
Otsuka America Pharmaceutical, Inc.4$96
Novo Nordisk Inc4$62
GlaxoSmithKline, LLC.2$28
GENZYME CORPORATION1$24
Tris Pharma Inc1$17
PFIZER INC.1$17
Aimmune Therapeutics, Inc.1$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$15

Products named: BREZTRI, REXULTI, UBRELVY, VRAYLAR, Ozempic, QULIPTA, TRELEGY ELLIPTA, FABRAZYME.

Industry payments across AR — which companies pay providers there.